Responsible development and implementation of AI
What are the issues, what is already in place, and what needs to be done?
Health technology innovation, including Artificial Intelligence (AI) development, is moving at a fast pace and with high expectations. It offers good opportunities to contribute to high-quality and affordable healthcare, but also raises many questions. In order to promote responsible development and implementation of AI, several ELSA (Ethical, Legal and Societal Aspects) labs are being set up in the Netherlands, in which researchers, societal partners, companies, citizens and patients work together.
In this business booster, will be explained how the ELSA lab Northern Netherlands (ELSA-NN) aims to contribute to responsible development and implementation of AI in health-care. Three ELSA-NN consortium partners will pitch how they are confronted with and handle Ethical, Legal, and Societal Aspects and what their questions and needs are in realizing responsible development and implementation of AI. With these introductions and discussion with the audience, we expected to receive an overview of the Ethical, Legal and Societal Aspects at stake, what is already in place and what needs to be done to realize the responsible implementation of AI.
Prof. dr. Claudine JC Lamoth – Professor of Movement Analysis, Smart Technology in Healthy Ageing at the University Medical Center Groningen, dep. of Human Movement Sciences (RUG) & General scientific director research center SPRINT
Mirjam Plantinga – Senior researcher and project leader at ELSA AI lab Northern Netherlands (ELSA-NN)
1. Rick Pleijhuis – Internist-allergologist/immunologist at University Medical Center Groningen (UMCG), Co-founder and Chief medical officer of Evidencio
2. Nephtis Brandsma – Chief Data Officer at the Gemeente Groningen
3. Marco D’Agata – Managing Director at Neolook Solutions
More information about ELSA-NN, visit the website.